Quantcast

Latest Galena Biopharma Stories

2014-08-06 12:28:13

Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the Antigen Express Novel Immunotherapeutic AE37 WORCESTER, Mass. and TORONTO, Aug. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study demonstrates an association between a specific immune...

2014-07-15 23:14:44

Targeted therapy for pancreatic cancer is based on personalized medicine approach Somerville, Massachusetts (PRWEB) July 15, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer announced today that Tozaride, the Company's lead candidate, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of pancreatic cancer. Pancreatic cancer is responsible for significant cancer...

2014-07-01 16:26:24

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Breast Cancer Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/generic_drugs/global_breast_cancer_drugs_market.html About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal...

2014-06-17 16:25:41

NEW YORK, June 17, 2014 /PRNewswire/ -- According to GLOBOCAN 2012, breast cancer was the second most commonly diagnosed form of cancer in 2012 with 1.7 million new cases, and accounting for nearly 12% of all new cancer cases. Since the 2008 estimates, breast cancer incidence has increased by more than 20% while mortality has increased by 14%. With approximately 522,000 deaths in 2012, breast cancer is now the most common cause of cancer death among women. Furthermore, it is...

2014-06-16 12:29:42

LONDON, June 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Vaccine Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/cancer_vaccine_partnering_terms_agreements_1.html The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer vaccine partnering...

2014-06-02 16:26:24

OAKLAND, Calif., June 2, 2014 /PRNewswire/ -- Patients with specific HER2+ breast cancer tumors have a low risk of the cancer recurring five years after diagnosis, even without chemotherapy or treatment with a common antibody, according to a Kaiser Permanente study published in the Journal of Clinical Oncology. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO Researchers reviewed 16,975 cases of breast cancer diagnosed in Kaiser Permanente patients between 2000 and 2006....

2014-05-28 23:19:13

Tozaride Targeted Therapy Shows Tumor Reduction in Animal Model Somerville, Massachusetts (PRWEB) May 28, 2014 Andarix Pharmaceuticals, a clinical stage company, announces that its Tozaride targeted pancreatic cancer therapy has been selected for abstract publication at the 2014 ASCO meeting in Chicago, IL, May 30-June 4. The abstract - e15224: Effect of rhenium Re188-P2045 (Tozaride) on tumor growth in the AR42J rat pancreatic tumor xenograft nude mouse model - is available online at...

2014-05-28 16:26:55

Educational and Awareness Raising Events Scheduled throughout the Month of June NEW YORK, May 28, 2014 /PRNewswire/ -- The Cancer Research Institute (CRI) is pleased to host its second annual Cancer Immunotherapy Month in June, aimed at increasing awareness of cancer immunotherapy, also known as immuno-oncology, a class of cancer treatment that mobilizes the immune system to fight the disease. Immunotherapy was named Science magazine's 2013 Breakthrough of the Year, and is anticipated once...

2014-05-28 12:31:30

LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ovarian Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/pipeline/ovarian_cancer.html Ovarian Cancer - Pipeline Review, H1 2014 SummaryGlobal Markets Direct's, 'Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development...

2014-05-20 08:34:45

WORCESTER, Mass. and TORONTO, May 20, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients with early stage breast cancer who receive AE37 may benefit in terms of reduced risk of relapse. The AE37 breast cancer vaccine is being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the 50(th)...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related